Composition, form of production and packaging
? Tablets from light yellow to yellowish-gray color, biconvex, with a weak specific odor peculiar to the rennet enzyme; inclusions of varying degrees of intensity, non-uniformly distributed on the surface of the tablet, are allowed.
1 tab.
abomin * 50 thousand MEU
Auxiliary substances: potato starch, calcium stearate.
10 pieces. - packings of cellular contour (1) - packs cardboard.
10 pieces. - packings cellular planimetric (2) - packs cardboard.
10 pieces. - packings cellular planimetric (3) - packs cardboard.
10 pieces. - Packings without cell contour.
* - rennet enzymes of calves and lambs of milk age (with a lactose content of at least 70%)
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2012.
PHARMACHOLOGIC EFFECT
The drug obtained from the mucous membrane of the stomach of calves and lambs of milk age. Contains the amount of proteolytic enzymes acting on food (mainly milk) proteins. It improves digestion in case of insufficient enzymatic activity of gastric juice.
PHARMACOKINETICS
Data on the pharmacokinetics of the drug Abomin В® are not available.
INDICATIONS
Diseases of the gastrointestinal tract, accompanied by a violation of the digestive capacity of gastric juice, including:
- Achilles;
- hypo- and anacid gastritis;
- indigestion;
- conditions after resection of the stomach;
- gastritis;
- gastroenteritis;
- Enterocolitis.
DOSING MODE
Children over 14 years of age and adults are prescribed 1 tablet per os. 3 times / day during meals for 1-2 months. With insufficient effectiveness, a single dose can be increased to 2-3 tablets. at the reception, and the course of treatment was extended to 3 months.
In acute gastritis, gastroenteritis and colitis - 1 tab. 3 times / day for 2-3 days.
SIDE EFFECT
From the digestive system: nausea, heartburn.
Other: allergic reactions.
CONTRAINDICATIONS
- Children under 14 years of age (for this dosage form);
- Hypersensitivity to the drug.
PREGNANCY AND LACTATION
Data on the safety of the use of the drug Abomin В® during pregnancy and lactation are not provided.
APPLICATION FOR CHILDREN
Contraindicated: children under 14 years (for this dosage form).
OVERDOSE
Cases of overdose are not established.
DRUG INTERACTION
Drug interaction of the drug Abomin В® is not described.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children, dry, protected from light at a temperature of 15 В° to 25 В° C. Shelf life - 2 of the year.
